OpenAlex · Aktualisierung stündlich · Letzte Aktualisierung: 11.04.2026, 21:13

Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.

AI-Augmented Ophthalmic Therapeutics

2025·0 Zitationen·BENTHAM SCIENCE PUBLISHERS eBooks
Volltext beim Verlag öffnen

0

Zitationen

1

Autoren

2025

Jahr

Abstract

Ophthalmic therapeutics faces persistent challenges in delivering individualized treatment strategies, predicting therapeutic outcomes, and optimizing long-term patient management across diverse disease profiles. Traditional treatment paradigms often rely on generalized clinical guidelines, which may not adequately account for patient-specific variations in disease progression, comorbidities, and therapeutic response. To address these limitations, this chapter introduces an artificial intelligence (AI)-driven framework to enhance precision in ophthalmic therapeutics by facilitating data-informed, personalized, and predictive care. It introduces key AI methodologies—including deep learning, federated learning, and knowledge graphenhanced modeling—and explores their application in the treatment of ophthalmic conditions, including age-related macular degeneration, diabetic retinopathy, and glaucoma. The chapter demonstrates how AI models contribute to individualized treatment planning, dosage optimization, and therapeutic outcome forecasting, thereby improving clinical efficacy and patient-centered care. In addition, the chapter introduces the integration of AI with Traditional Chinese Medicine (TCM) practices in ophthalmology, offering evidence-based evaluations of acupuncture, herbal therapies, and multimodal treatment protocols through AI-supported validation frameworks. Real-world case studies are presented to highlight AI-assisted innovations in ophthalmic surgery, stem cell therapy, and longitudinal patient monitoring. These case studies illustrate how AI enhances both mechanistic understanding and clinical outcomes. Moreover, the chapter critically examines the ethical, regulatory, and operational challenges involved in deploying AI in therapeutic contexts, including data privacy, model interpretability, and the standardization of AI applications in diverse clinical environments. By bridging algorithmic innovation with therapeutic practice, this chapter provides a comprehensive foundation for researchers, clinicians, and healthcare stakeholders aiming to advance the next generation of ophthalmic care. It underscores the transformative potential of AI in redefining ophthalmic therapeutics and outlines a strategic roadmap for responsible, scalable, and patient-specific AI integration in the evolving landscape of precision medicine.

Ähnliche Arbeiten

Autoren

Institutionen

Themen

Machine Learning in HealthcareArtificial Intelligence in Healthcare and EducationTraditional Chinese Medicine Studies
Volltext beim Verlag öffnen